MRD / Regn No. : 20180000725 Date : 14/07/2026
Patient Name : Vasanthkumar Krishnan Dr Age & Gender : 41 Yrs. / Male
Contact No. : 9786066004 UHID :
Ht / Wt / BMI : 161 / 70.5 / 27.20 BP S / BP D : 145 / 90
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DM (22/Aug/2018) |
Subjective : NO NEW COMPLAINTS,TRANSIENT DYSPEPSIA,MISSED TIRZEPATIDE
Objective : NAD
Analysis : TYPE 2 DM WORSENED CONTROL
Plan : INCREASE INSULIN TO 24 UNITS,CONTINUE TIRZEPATIDE 12.5 MG,ADD HYQSEE ME IN 1 MONTH WITH FBS 2HPP  
Salient Investigations : FASTING PLASMA GLUCOSE (FPG): 250 mg/dL | GLYCOSYLATED HEMOGLOBIN (HBA1C): 9.1 % | POST PRANDIAL GLUCOSE (2HPP): 346 mg/dL
S# Generic (Trade) Name Route Dosage Usage Duration
1 EMPAGLIFLOZIN 25 MG
JARDIANCE 25 MG
PO 1-0-0 BEFORE FOOD
TILL NEXT VISIT
2 INJ GLARGINE
TOUJEO
PO 0-0-18 UNITS AT BEDTIME
TILL NEXT VISIT
3 ROSUVASTATIN 10 MG
CRESTOR 10 MG
0-0-1 AT BEDTIME
TILL NEXT VISIT
MAY
4 INJECTION TIRZEPATIDE 12.5 MG
MOUNJARO
Medicine For OBESITY DIABETES
SQ ONCE A WEEK AS DIRECTED NO RELATION TO FOOD
TILL NEXT VISIT
MAY CAUSE NAUSEA VOMITING DIARRHEA OR AVERSION TO CERTAIN FOODS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 13/Aug/2026
Tests Suggested For Next Visit : FBS 2HPP SMBG
   
   

Dr. Krishna G Seshadri
Sr. Consultant Endocrinology Diabetes and Metabolism
Tamil Nadu / 48748 HPRID: 71-0638-2075-7542

This is a Computer generated Prescription

Powered By: